Abstract:Background/Aims: Cellular hypertrophy is an early important pathological feature of renal diseases such as diabetic nephropathy and remnant kidney. Recent studies have demonstrated that angiotensin II (Ang II) might be a major contributor in regulating cell hypertrophy. However, the exact mechanism is still unclear. The aim of our present work was to investigate the possible role of a newly clarified fibrogenic factor, connective tissue growth factor (CTGF), in mediating the effect of Ang II-induced tubular cell hypertrophy. Methods: The cell line HK2 was grown in Dulbecco’s modified Eagle’s medium containing 10% heat-inactivated fetal calf serum. After the cells were rested in serum-free medium for 24 h, the dose and time response of CTGF mRNA expression to Ang II stimulation was observed by RT-PCR, and protein synthesis was observed by Western blotting. The effect of anti-CTGF on Ang II (10–7M)-induced [3H]-leucine incorporation, total protein content (Coomassie brilliant blue G250 method) and change in cellular size [determined by a scanning electronic microscope (SEM)] was also observed. The influence of anti-CTGF antibody on the cell cycle was analyzed by using a fluorescence-activated cell sorter flow cytometer. Results: The results showed that Ang II induced expression of CTGF mRNA in a time- and dose-dependent manner (p < 0.05 and 0.01, respectively). Stimulation of cells with Ang II (10–7M) for 48 h resulted in a 92% increase in [3H]-leucine incorporation (5,584 cpm/105 cells at 0 h vs. 10,741 cpm/105 cells at 48 h; p = 0.01), which was significantly abolished by treatment with anti-CTGF antibody. Ang II (10–7M) significantly increased the total protein content in HK2 cells (control: 0.169 ± 0.011 mg/105 cells vs. Ang II: 0.202 ± 0.010 mg/105 cells; p = 0.03), which was markedly inhibited by cotreatment with anti-CTGF antibody. The average cellular diameter determined by SEM showed that the increase in cell size induced by Ang II could be significantly inhibited by anti-CTGF antibody (control: 11.92 ± 1.62 µm, Ang II group: 20.63 ± 3.83 µm, Ang II + anti-CTGF group: 16.43 ± 3.23 µm; p < 0.01, respectively). Furthermore, the flow cytometer study showed that Ang II arrested the cell cycle at G0–G1 phase, which was significantly reversed by treatment with anti-CTGF antibody (G0–G1 percentage: in Ang II group: 76 ± 1.8%, in Ang II + anti-CTGF group: 71 ± 1.78%; p = 0.04). Conclusion: Our data are the first to clearly demonstrate that CTGF might be an important mediator of Ang II-induced renal hypertrophy, which suggests that inhibiting the production of CTGF might be the new strategy in early prevention of renal fibrosis.

Regulation of epithelial mesenchymal transition by the renin-angiotensin system: a role for klotho in renal tubular epithelial cells

Klotho retards renal fibrosis through targeting mitochondrial dysfunction and cellular senescence in renal tubular cells

Klotho Regulates Epithelial-to-Mesenchymal Transition in Vitro Via Wnt/β-Catenin Pathway and Attenuates Chronic Allograft Dysfunction in a Rat Renal Transplant Model.

Oleanolic Acid Attenuates TGF-β1-induced Epithelial-Mesenchymal Transition in NRK-52E Cells

Nanoparticle-mediated Klotho Gene Therapy Prevents Acute Kidney Injury to Chronic Kidney Disease Transition Through Regulating PPARα Signaling in Renal Tubular Epithelial Cells

TGFβ-incurred Epigenetic Aberrations of Mirna and DNA Methyltransferase Suppress Klotho and Potentiate Renal Fibrosis

Long Noncoding RNA NEAT1 is Involved in the Protective Effect of Klotho on Renal Tubular Epithelial Cells in Diabetic Kidney Disease Through the ERK1/2 Signaling Pathway

Effect of Nuclear Factor Κb Antisense Oligodeoxynucleotides on Transforming Growth Factor Β1-Induced Epithelial Mesenchymal Transition in Human Renal Tubular Epithelial Cells

KLF 15 Works as an Early Anti-Fibrotic Transcriptional Regulator in Ang II-Induced Renal Fibrosis via Down-Regulation of CTGF Expression

Klotho-derived peptide 1 inhibits cellular senescence in the fibrotic kidney by restoring Klotho expression via posttranscriptional regulation

Aerobic exercise up-regulates Klotho to improve renal fibrosis associated with aging and its mechanism

Klotho is Regulated by Transcription Factor Sp1 in Renal Tubular Epithelial Cells

Upstream and Downstream Regulators of Klotho Expression in Chronic Kidney Disease

Abstract 13254: Klotho Suppresses Endothelial-to-Mesenchymal Transition in the Aorta of Mice With Chronic Kidney Disease by Inhibition of Endothelial Senescent Activity

Role of Connective Tissue Growth Factor in Mediating Hypertrophy of Human Proximal Tubular Cells Induced by Angiotensin II.

Alantolactone alleviates epithelial-mesenchymal transition by regulating the TGF-β/STAT3 signaling pathway in renal fibrosis

The Protective Function of Αklotho in Chronic Kidney Disease: Evidence and Therapeutic Implications

Egr-1 mediates chronic hypoxia-induced renal interstitial fibrosis via the PKC/ERK pathway

Klotho Down-Regulates Egr-1 by Inhibiting TGF-β1/Smad3 Signaling in High Glucose Treated Human Mesangial Cells.

Inhibitory Role of the KEAP1-NRF2 Pathway in TGFβ1-Stimulated Renal Epithelial Transition to Fibroblastic Cells: A Modulatory Effect on SMAD Signaling

Kindlin-2 Regulates Renal Tubular Cell Plasticity by Activation of Ras and Its Downstream Signaling